Budget Battles
-
Republicans Want Strings Attached to California Disaster Aid
-
Biden Goes Out With a Bang in the Jobs Market
-
Trump Privately Pushes Senators for ‘One Big, Beautiful Bill’
-
Trump Considers Declaring National Emergency for Tariff Rollout
-
Trump Unloads: Grievances, Greenland and the Gulf of Mexico
-
Republicans Divided Over How to Pass Trump’s Agenda
-
Trump Pushes Johnson to Victory as Speaker
-
It May Sound Awful, but We Really Do Need to Pay for Human Organs
By Marc JoffeWith dialysis being so expensive, onerous and ultimately fatal, kidney patients and taxpayers would be better off with more donations.
-
Feds' Big Bust: $1.3 Billion Health Insurance Fraud Takedown
By Rob GarverOn the same day that Republican members of the Senate released a pair of bills aimed at repealing and replacing the Affordable Care Act, the Department of Justice highlighted a problem with the...
-
Where Do You Store Your Medical Info? Apple Wants It to Be Your iPhone
By Christina Farr, CNBCImagine turning to your iPhone for all your health and medical information — every doctor's visit, lab test result, prescription and other health information, all available in a snapshot on your...
-
How American Health Care Became a Big, Broken Business
Who’s to blame for the sad state of the American health care system in 2017? The short answer, as Dr. Elisabeth Rosenthal details in her new book “An American Sickness: How Healthcare Became Big...
-
Why You Should Think Twice Before Drinking That Can of Soda
By Barbara MoranNew research suggests that excess sugar—especially the fructose in sugary drinks—might damage your brain.
-
One Major Obamacare Insurance Company Is Close to Break Even This Year
By Eric PianinDespite high premiums and diminished consumer choices that might deter consumers from enrolling in Obamacare, a new financial analysis concludes that the individual health insurance market has shaken...
-
New Cancer Drugs Show Promise – and Sky-High Prices
By DEENA BEASLEY, ReutersNewer cancer drugs that enlist the body's immune system are improving the odds of survival, but competition between them is not reining in prices that can now top $250,000 a year. The drugs' success...
-
The Billion Dollar Drug for Opioid Victims Has a Problem: It’s Addictive
Maryland Gov. Larry Hogan’s executive order earlier this month, declaring the state’s opioid addiction crisis a state of emergency, is yet another example of the state’s leadership in addressing a...
-
Pfizer Chief Says Government Efforts to Contain Drug Prices Will Backfire
By Eric PianinIan C. Read, Pfizer’s hard-edged, Scottish-born CEO and chairman, has been unapologetic about his company’s dubious pricing practices. Last week, he gave no ground on the larger question about...
-
Trump’s Big Cuts to Medical Research May Not Get Past Congress
By Eric PianinNIH, Donald Trump, Paul Ryan, Joe Biden, cancer research, National Institutes of Health
-
Obamacare May Lose UnitedHealth: Will It Hurt?
By Millie DentA little more a month after UnitedHealth Group, the nation’s biggest health insurer, said it would expand its presence in Obamacare exchanges, the company is now saying it is pulling back on...
-
The Most Hated Health Insurance Company of 2015
By Millie DentTo say that Americans don’t like their health insurance companies may be putting it mildly. In a recent survey asking consumers to rank their satisfaction with companies across 43 industries, health...
-
Health Insurance Hackers Put 154 Million Consumers at Risk
By Eric PianinLast February, health insurance giant Anthem Inc. revealed stunning news: Hackers invaded the company’s massive computer system and gained access to sensitive personal and medical information of 78.8...
-
Americans Give Health Insurers a Big Thumbs Down
By Millie DentAmericans haven’t been this fed up with health insurance companies in a decade, and their frustration likely won’t fade soon. Consumer satisfaction with health insurance providers fell to the lowest...
-
3 Ways Mega-Rich Investors Could Cut Your Drug Prices
By Janna HerronShares of Valeant Pharmaceuticals continue to dive after a seething report issued this month by investors betting against the company compared it to Enron and critics questioned its drug-pricing and...